-
Product Insights
NewNuProbe Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our NuProbe Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. NuProbe Inc (NuProbe) develops ultra-sensitive and highly multiplexed assays for noninvasive cancer profiling on qPCR/Sanger, NGS, and Nanopore. NuProbe is headquartered in Houston, Texas, the US. GlobalData's Medical Devices company profile report, “NuProbe Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and...
-
Product Insights
NewPreventionGenetics LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our PreventionGenetics LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. PreventionGenetics LLC (PreventionGenetics) is a healthcare solutions company that offers laboratory testing services. The company offers NextGen sequencing, sanger sequencing and deletion and duplication testing. It provides clinical DNA testing services such as price list by disease, cancer tests, billing and cpt codes, prenatal guidelines, targeted variants, array CGH test, order testing kits, price list by gene, forms and specimen...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA test market size was $4.3 million in 2023. The considerable increase in the incidence of breast and ovarian cancer will drive the BRCA tests market to grow at a CAGR of more than 3% during 2023-2033. Rates of BRCA1/2 testing have increased in recent years. This is due to a lowering in the costs associated with BRCA1/2 screening, increased public awareness, and the availability of PARP inhibitors to treat breast and ovarian cancer...
-
Sector Analysis
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
EGFR Tests Market Report Overview The EGFR tests market size was $17.4 million in 2023 and it will grow at a CAGR of less than 1% during 2023-2033. Epidermal growth factor receptor gene (EGFR) tests are carried out to detect mutations within this receptor gene in non-small cell lung cancer tumor cells. The outcome of may determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating non-small cell lung cancer (NSCLC). EGFR Tests Market...
-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
KRAS Tests Market Report Overview The KRAS tests market size was valued at $37.1 million in 2023 and will grow at a CAGR of more than 7% during 2023-2033. Kirsten rat sarcoma virus (KRAS) gene tests are carried out to detect gene mutations in patient tissue samples; the outcome of which may guide therapies to treat various cancers including colorectal cancer, certain lung cancers, and some leukemias. KRAS Tests Market Outlook 2023-2033 ($ Million) Buy Full Report for More Insights...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRAF Tests Market Report Overview The BRAF tests market size was valued at $14.2 million in 2023. Factors including increasing incidence of melanoma and colorectal and lung cancers will drive the BRAF tests market to grow at a CAGR of more than 6% during 2023-2033. Mutation testing from formalin-fixed paraffin-embedded tumor tissue is standard practice for metastatic melanoma and can be performed on multiple sample types including resected specimens, biopsies, and needle biopsies. The most important factors to ensure quality...
-
Product Insights
Blue Star Land/ Crossland Const – Sanger Industrial Park – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Blue Star Land/ Crossland Const - Sanger Industrial Park - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
NeoGenomics Inc – Company Profile
NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies including cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry and molecular genetics including Sanger sequencing and fragment analysis. NeoGenomics cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases and fluorescence. Its in-situ hybridization testing services for detecting and locating the presence or absence of specific DNA sequences and genes on...
Add to Basket -
Report Bundle
56% offTrends in Medical Devices – Report Bundle (7 Reports)
A rise in disease awareness, improved accessibility to personalized medicine, and technological advancements are transforming the medical device industry. It is helping patients to avoid potential adverse events and reducing unnecessary hospitalizations and outpatient costs. The field has expanded from a handful of drug manufacturers to include many high-end manufacturers. Accessing the in-depth insight from the Trends in Medical Devices bundle can help you: Make informed decisions about investments, partnerships, and product development Understand your competitors’ strengths and weaknesses, identify areas...